Showing results (241-250 of 249) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 249 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 1, 2026
Chemotherapy for patients with circulating tumour DNA positive, stage II colon cancer (CIRCULATE) - an AIO / ABCSG trialG Folprecht, S Stasik, A Reinacher-Schick, et al.
The British Journal of Surgery|March 4, 2021
Preoperative portal vein or portal and hepatic vein embolization: DRAGON collaborative group analysisJ Heil, R Korenblik, F Heid, et al.
Ecancermedicalscience|January 28, 2015
Report from the OECI Oncology Days 2014Wh van Harten, G Stanta, G Bussolati, et al.
Transplantation Proceedings|November 18, 2008
Liver transplantation for hilar cholangiocarcinoma: a German surveyG M Kaiser, G C Sotiropoulos, K W Jauch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 8, 2021
International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancerS Novello, V Torri, C Grohe, et al.
Acta Chirurgica Belgica|February 27, 2009
Immunosuppression in pancreas transplantation: the Euro SPK trials and beyondJ Malaise, A De Roover, J P Squifflet, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?D William, M Bermúdez, A Kübler, et al.
Zeitschrift Fur Gastroenterologie|November 19, 2013
[Diagnosis of and therapy for hepatocellular carcinoma]T F Greten, N P Malek, S Schmidt, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 21, 2022
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancersA Jahn, A Rump, T J Widmann, et al.
Pageof 25